ShareProphets

The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join ShareProphets at less than 2p per article

> All the big AIM fraud exposés

> 300 articles and podcasts a month

> Hot share tips

> Original investigations by our experienced team

> No ads, no click-bait, no auto-play videos

Find out more

Tom Winnifrith Bearcast - I doff my cap to Jim Mellon but caveat emptor

By Tom Winnifrith | Tuesday 14 August 2018


Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


In today's bearcast my mind is a bit elsewhere as I explain HERE. But I cover SalvaRX (SALV), Optibiotix (OPTI), the fraud MySquar (MYSQ) and Falanx (FLX). PS For the avoidance of doubt, re Optibiotix, Mr Lemming Investor is not a Bulletin Board Moron, he is way above that - admittedly low - level of the human race. PPS I see he has posted again, I take it back, Mr Lemming is a pompous a'hole 


Filed under:




This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.


Comments

Comments are turned off for this article.


Site by Everywhen